Chronic Low Grade Inflammation in Pathogenesis of PCOS
Open accessThe DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant clinical implications and can lead to health problems related to the accumulation of adipose tissue, such as obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. There is also evidence that PCOS patients are at higher risk of cardiovascular diseases, atherosclerosis, and high blood pressure. Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation. According to known data, inflammatory markers or their gene markers are higher in PCOS patients. Correlations have been found between increased levels of C-reactive protein (CRP), interleukin 18 (IL-18), tumor necrosis factor (TNF-α), interleukin 6 (IL-6), white blood cell count (WBC), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) in the PCOS women compared with age- and BMI-matched controls. Women with PCOS present also elevated levels of AGEs and increased RAGE (receptor for advanced glycation end products) expression. This chronic inflammatory state is aggravating by obesity and hyperinsulinemia. There are studies describing mutual impact of hyperinsulinemia and obesity, hyperandrogenism, and inflammatory state. Endothelial cell dysfunction may be also triggered by inflammatory cytokines. Many factors involved in oxidative stress, inflammation, and thrombosis were proposed as cardiovascular risk markers showing the endothelial cell damage in PCOS. Those markers include asymmetric dimethylarginine (ADMA), C-reactive protein (CRP), homocysteine, plasminogen activator inhibitor-I (PAI-I), PAI-I activity, vascular endothelial growth factor (VEGF) etc. It was also proposed that the uterine hyperinflammatory state in polycystic ovary syndrome may be responsible for significant pregnancy complications ranging from miscarriage to placental insufficiency. In this review, we discuss the most importance evidence concerning the role of the process of chronic inflammation in pathogenesis of PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“COCs also exacerbate the inflammatory state present in these patients, which is likely related to increased aldosterone–renin ratio and CRP [12,14].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“The release of inflammatory markers is associated with long-term metabolic complications and high cardiovascular risk [12].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Compared with control women, patients with PCOS presented higher circulating concentrations of markers such as homocysteine, asymmetric dimethylarginine, and increased superoxide dismutase activity and decreased glutathione levels and paraoxonase-1 activity [2].”
BackgroundMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186 · cited 1×
“Obesity is a metabolic condition characterized by chronic inflammation state with higher pro-inflammatory cytokines, chemokines, and oxidative stress (OS) markers levels [5,6].”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Metabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Cited by
Items 401–500 of 731
CDH4/UBA1/RBMX axis promotes polycystic ovary syndrome progression through YAP1 activation
Xu, N., Yu, B., Li, Y., Yang, Y., Wang, Y., Fang, L., Wu, H., Luan, Y., & Yin, C. C. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00900-4 · Cited by 2
Circadian misalignment in PCOS: role of sleep and light
Samaddar, S., Ghosh, S., Kumar, A., Yadav, P., Yadav, M., & Dahiya, R. (2026) · Biological Rhythm Research · doi:10.1080/09291016.2026.2651558 · Cited by 3
Effects of physical exercise on menstrual symptoms in polycystic ovary syndrome: a systematic review
Molinaro, M., Greco, F., Ingargiola, A., Raffa, A., Greco, E. A., Emerenziani, G. P., & Aversa, A. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02836-0 · Cited by 2
Diagnostic Criteria and Genetic Basis of Polycystic Ovary Syndrome: A Narrative Review
Cepero-González, M. D. L. A., Aguilar-Galarza, A., Rodríguez-García, V. M., García-Gasca, T., & Moreno‐Celis, U. (2026) · Metabolites · doi:10.3390/metabo16040277 · Cited by 4
Gut microbiota in PCOS: key microbial changes, potential mechanisms and clinical applications
Shi, S., Ma, J., Jing, X., Jia, W., & Sun, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08352-2 · Cited by 2
Dhaliwal, J. (2022) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.409 · Cited by 2
Sun, D., Zhao, Y., & Wu, X. (2023) · PubMed Central · doi:10.22038/ijbms.2023.68784.14993 · Cited by 3
Statins for women with polycystic ovary syndrome not actively trying to conceive
Xiong, T., Fraison, É., Kolibianaki, E., Costello, M., Venetis, C. A., & Kostova, E. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008565.pub3 · Cited by 4
Bai, X., Zheng, C., Yu, Y., Zhang, J., Cao, S., Hou, C., & Wang, S. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.101908 · Cited by 2
Zhao, J., Fu, S., & Chen, Q. (2024) · Ginekologia Polska · doi:10.5603/gpl.94879 · Cited by 2
Prolidase activity in women with polycystic ovarian syndrome undergoing assisted conception
Erdoğan, K., Özen, E. U., Kahyaoğlu, İ., Neşelioğlu, S., Erel, Ö., Akar, S., Özdemir, Ö., Ercan, C. M., & Üstün, Y. E. (2024) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2024.2346228 · Cited by 2
Factors contributing to variability in metformin concentration in polycystic ovary syndrome
Nikolic, V. N., Stefanović, M., Mitić, D., Sunaric, S. M., Jović, M., Trajković, H., Stankovic, S. D., Ignjatović, A., & Stokanović, D. (2024) · Croatian Medical Journal · doi:10.3325/cmj.2024.65.138 · Cited by 2
Barman, I., Sharma, T., & Talukdar, N. (2024) · Journal of Young Pharmacists · doi:10.5530/jyp.2024.16.25 · Cited by 2
Karavani, G., Gutman‐Ido, E., Dick, A., Vedder, K., Cohen, N., Mordechai-Daniel, T., Sussman, R. G., & Imbar, T. (2024) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2023.0157 · Cited by 2
Prodromos, C. C. (2024) · American Journal of Stem Cells · doi:10.62347/tczf4814 · Cited by 2
Zhao, Y., Liu, L., Hao, J., Wang, H., Cao, Y., Lan, Y., & Ji, L. (2024) · Medicine · doi:10.1097/md.0000000000040229 · Cited by 2
Chen, T., Chen, M., & Lien, K. (2024) · Otolaryngology · doi:10.1002/ohn.1081 · Cited by 2
Mishra, S., & Mittal, P. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100741 · Cited by 3
Liu, Y., Bai, H., Guan, H., Wang, C., Song, X., Yong, Z., Guo, X., Li, L., & Zhang, Z. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2454432 · Cited by 2
Li, X., Li, Y., Zhang, B., Wang, J., Yang, Y., & Du, Y. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01647-w · Cited by 2
Aldaihani, L., Maqames, S., Albuloushi, M., Al-Yousef, R., Almansori, M., Almutairi, M., Al-Terki, A. E., Yaiesh, S. M., & Al-Shaiji, T. F. (2025) · Obstetrics and gynecology. · doi:10.5772/intechopen.1011577 · Cited by 2
Moini, A., Dashtkoohi, M., Haghollahi, F., Abiri, A., & Tajik, N. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01135-w · Cited by 4
Gashti, N. G., Hajizadeh, K., Farshbaf‐Khalili, A., Mahdipour, M., & Shahnazi, M. (2025) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr38965 · Cited by 4
Survey based on classification of PCOS using gene expression
Poorani, B., & Kalaivani, A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns3.9225 · Cited by 2
İşbilen, E., & Karuserci, Ö. K. (2022) · Experimed · doi:10.26650/experimed.1111483 · Cited by 3
Dehparvar, N., Alijaniha, F., Mozaffarpur, S. A., Niasari-Naslaji, A., Bahaeddin, Z., Garshasbi, A., Gholami-Fesharak, M., & Naseri, M. (2022) · Journal of Medicinal Plants · doi:10.52547/jmp.21.83.1 · Cited by 5
Genetic basis of metabolism and inflammation in PCOS
Pang, Y., Zhao, Y., & Qiao, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00002-2 · Cited by 3
Review of Decreased IL-6 Levels in SOPK-Insulin Resistant Rats fed a Low Carb High Protein Diet
Aryani, H. P., Wati, D. R., & Sugiyanta, S. (2023) · Adi Husada Nursing Journal · doi:10.37036/ahnj.v9i2.496 · Cited by 3
Clitoria Ternatea as a Potential Herb in Polycistic Ovary Syndrome
Kurniawati, E. Y., Pramono, N., Hidayat, S., Mahati, E., & Santana, C. I. B. (2024) · International Journal of Medicinal Plants and Natural Products · doi:10.20431/2454-7999.1001001 · Cited by 2
Albayati, H. B. M., & Abdulhameed, W. A. (2024) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v6i1.558 · Cited by 2
Dehparvar, N., Garshasbi, A., Niasari-Naslaji, A., Alijaniha, F., Fesharaki, M. G., Ghaffari, F., & Naseri, M. (2024) · PubMed Central · doi:10.22038/ajp.2023.23122 · Cited by 2
Sun, B. H., Pan, Z., Kuang, H., Feng, X., Hou, L., Xu, F., Song, F., & Sun, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.14.500077 · Cited by 3
Role and mechanism of alpa1-antitrypsin in polycystic ovary syndrome
Pan, S., Aizezi, Y., Wang, H., Lu, Y., & Xue, B. (2022) · Saudi Medical Journal · doi:10.15537/smj.2022.43.12.20210398 · Cited by 2
Polikistik Over Sendromuna Multidisipliner Yaklaşım
Elgün, T. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub80.c269 · Cited by 1
Xu, H., & Wang, G. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5101004 · Cited by 1
Effects of antioxidant supplementation for polycystic ovary syndrome
Łopacińska, O., Stańczyk, K., Korn, A., Czarnecka, K., Wójcik, E., Korczak, A., Jędrzejczyk, J., Szewczyk, O., Olek, E., & Burda, K. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.61.50695 · Cited by 2
Mashhadi, F., Ghaebi, N. K., Roudi, F., & Nematy, M. (2024) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-024-01997-3 · Cited by 1
PCOS – The Importance of Diet, Physical Activity, and Other Non-Pharmacological Methods in Treatment
Turek, M., Wojciechowska, K., Jaroń, A., Jastrzębska, K., Wiklińska, A., Witkowska, M., Skotnicka, J., Błaszczak, K., Borkowski, A., & Sawicki, M. (2024) · Quality in Sport · doi:10.12775/qs.2024.19.53833 · Cited by 1
Wu, Y., Qin, L., He, G., Luo, Z., & Luo, S. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303308816240918062247 · Cited by 1
Allagui, I., Sdayria, J., Athmouni, K., Zammel, N., Guesmi, F., Saoudi, M., Giuffrè, A. M., Allagui, M. S., Nahdi, S., & Harrath, A. H. (2024) · 3 Biotech · doi:10.1007/s13205-024-04169-2 · Cited by 1
Fatima, S., Mohapatra, L., Mishra, D., Tripathi, A. S., & Khan, A. A. H. (2025) · Reproductive Sciences · doi:10.1007/s43032-024-01771-w · Cited by 1
Dong, F., Zhang, W., Sun, B., Niu, W., Zhai, J., Guo, Y., & Wang, F. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673357582241223070335 · Cited by 1
Mehmood, Q., Latif, H., Yasin, F., Ali, S., Yasin, A. L. F., & Shahid, H. (2024) · medtigo Journal of Medicine · doi:10.63096/medtigo30622415 · Cited by 1
Psycho-Neuroendocrine Regulation of Autoimmune Dysfunction in Polycystic Ovary Syndrome
Jeni, A., & Reddy, K. J. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7432-0.ch021 · Cited by 1
Polikistik Over Sendromu Olan Ergenlerde Oksidatif Stres Parametrelerinin Değerlendirilmesi
Arı, D. A., Kızılkan, M. P., Güven, A. G., Kanbur, N., Derman, O., Erel, Ö., & Akgül, S. (2025) · Güncel Pediatri · doi:10.4274/jcp.2025.65768 · Cited by 1
Çelikdemir, N., Mamur, M. N., Çeribaşı, A. O., Üstün, İ., Yılmaz, S., & Kaya, E. (2025) · Revista Científica de la Facultad de Ciencias Veterinarias · doi:10.52973/rcfcv-e35619 · Cited by 1
Divya, Thakur, A., Hajam, Y. A., & Kumar, R. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100278 · Cited by 1
PATEL, N., Shaker, I. A., & PATEL, K. (2025) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2025v18i6.54774 · Cited by 1
Tenascin-C levels in polycystic ovary syndrome and polycystic ovarian morphology
Koksal, M. K., Öztürk, U. K., Keleş, E., Arslan, B., & Üstün, Y. E. (2025) · Northern Clinics of Istanbul · doi:10.14744/nci.2024.03295 · Cited by 2
Ovarian aging, cardiovascular risk and inflammation: insights from the OVA study
Verhaeghe, C., Lindquist, K. J., Bleil, M. E., Rosen, M., Redberg, R., Haisenleder, D. J., McCulloch, C. E., & Cedars, M. I. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01754-8 · Cited by 1
Gong, X. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01968-7 · Cited by 1
Upadhyay, S., Mazumder, A., & Das, S. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128382284250822045319 · Cited by 1
Wen, J., Zhang, F., Cheng, G., Liu, C., & Zhang, Y. (2025) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2025.2555173 · Cited by 2
Li, R., Chen, Q., Yan, Y., Yang, Y., & Hu, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-18867-1 · Cited by 1
Bashir, M., Amin, F., Amin, H., Teli, T., & Tali, T. A. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20253125 · Cited by 2
Mussa, B. M., Srivastava, A., Rajan, R., Venkatachalam, T., Al-Habshi, A., Abdelgadir, E., Bashier, A. M., Alawadi, F., Hafidh, K., Hamoudi, R., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-03105-1 · Cited by 1
Defrin, D., Birru, A., Cuandra, K., Puspita, R., Widnyana, I., Aqilah, N. M., Fadhilla, A., Suwardjo, W., Amalia, A., Haq, K., et al. (2025) · F1000Research · doi:10.12688/f1000research.166678.2 · Cited by 1
Yin, Q., Liu, Y., Zhang, G., Cao, Y., & Zheng, J. (2025) · BMC Women s Health · doi:10.1186/s12905-025-04018-1 · Cited by 1
Yu, H., Guo, Y., Ling, Y., Su, Y., & Li, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-20980-0 · Cited by 1
Zhang, H., Di, M., Wang, Y., Ma, Y., Gou, Y., & Zhou, Z. L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1671511 · Cited by 1
Jiang, Q. Y., Pu, D., Hu, Y., Wu, R., Jiang, C., Yuan, S., Zhu, X., & Xu, L. (2025) · Medicine · doi:10.1097/md.0000000000046163 · Cited by 1
Chen, L., Wei, C., Gao, L., & Lu, D. (2025) · PeerJ · doi:10.7717/peerj.20467 · Cited by 1
Metformin in the Treatment of Polycystic Ovary Syndrome: A Literature Review
Juda, A., Rojek, K., Kamińska, M., Strzoda, A. J., Strzoda, A., Sowiński, W. J., Zdybel, M., & Strzoda, A. (2025) · International Journal of Infertility & Fetal Medicine · doi:10.5005/jp-journals-10016-1397 · Cited by 1
Activation and DNA methylation of PANoptosis in polycystic ovary syndrome
Han, Y., Han, Y., Feng, Y., Shan, Y., Liu, C., Wang, K., Li, X., Zhang, S., & Zhu, X. (2026) · PLoS ONE · doi:10.1371/journal.pone.0338342 · Cited by 1
Hosein, M.-R., & Housein, Z. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11436-3 · Cited by 1
Wei, S., Qin, T. G., Li, Y., Zhang, D., Liu, L. A., Wei, L., & Zhao, R. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04970-7 · Cited by 1
Mashhadi, F., Ghaebi, N. K., Rakhshandeh, H., Khadem‐Rezaiyan, M., Roudi, F., & Nematy, M. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-025-01867-0 · Cited by 3
Zhang, Y., Huang, K., Nong, W., Guo, Z., Xie, Q., Lei, X., Zhang, S., Li, M., & Zhang, J. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-01996-0 · Cited by 1
Abduljabbar, H., Jamal, M., & Esmat, A. (2026) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010433981251031050335 · Cited by 1
Lu, Y., Li, L., Fang, J., Ju, W., Yan, Y., & Wu, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1739230 · Cited by 3
Shirasath, K. R., Karwasra, R., Ahmed, N. Z., Kumar, P., Alam, S., Goyal, S. N., & Agrawal, Y. O. (2026) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70228 · Cited by 1
Дикке, Г. Б., Мудров, В. А., Efendieva, R. M., & Абусуевна, А. З. (2026) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2026.688 · Cited by 1
Nigella sativa: Pharmacological Insights and Bioactive Therapeutics
., M.-U.-H., Sharma, A., Mittal, V., ., N., & ., P. (2026) · Letters in Functional Foods · doi:10.2174/0126669390365086251202104340 · Cited by 1
Luo, M., Chen, Y., Chen, H., & Wen, Y. (2026) · Inflammation Research · doi:10.1007/s00011-025-02160-y · Cited by 1
Amer, N. A., Aldababseh, S. B., Gawad, D. A. H. A., Abdelsadek, M. M., Gouda, R. A., & Kinki, A. B. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02075-0 · Cited by 2
Dou, L., Tang, Y., Yuan, S., Xu, F., Wang, Y., He, Q., & Yan, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073068 · Cited by 1
Zhu, X., Xu, W., & Lu, A.-F. (2026) · Reproductive Toxicology · doi:10.1016/j.reprotox.2026.109233 · Cited by 1
Shi, H., Liu, Q., Zhong, L., Zhou, M., Zhang, T., & Lei, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-47165-7 · Cited by 1
A case control study of subjective sleep characteristics and polycystic ovary syndrome
Zhuang, X., Zhang, S., Fu, R., Cai, C., Yin, J., Shi, W., Cen, J., & Ji, X. (2026) · Scientific Reports · doi:10.1038/s41598-026-50477-3 · Cited by 1
Uluğ, E., Aksun, S., Pinar, A. A., & Yıldız, B. O. (2026) · British Journal Of Nutrition · doi:10.1017/s0007114526107405 · Cited by 1
Jamshaid, M., Sheikh, A. A., Jamshaid, W., Shafiq, H., & Ahmed, M. H. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103577 · Cited by 1
Sun, H., Xu, J., Pan, C., Song, J.-L., & Zhou, Y. (2026) · Metabolites · doi:10.3390/metabo16050332 · Cited by 1
ALATAŞ, H., Arslan, N., KESKİN, L., & Ağralı, C. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s586793 · Cited by 1
Vitamin D status tracks inflammation perfusion and pregnancy in polycystic ovary syndrome
Wang, K., Wang, R., Cai, Z., Ma, J. H., Li, G., & Wang, F. (2026) · iScience · doi:10.1016/j.isci.2026.116120 · Cited by 1
Increased mortality in polycystic ovary syndrome— a cohort study
Piltonen, T., Koskenkari, N. V. S., Koivuaho, E., Morin-Papunen, L. C., Hurskainen, E., Gissler, M., Arffman, R. K., & Ollila, M. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag080 · Cited by 1
Brain alteration of PCOS: neuroimaging and function
Jiang, N., Deng, J., 鲍昌金, Yin, H., Zhang, X., Ding, Y., Zhang, S., Xu, Y., Diao, X., Lu, K., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1825907 · Cited by 1
Zhou, R., Wang, Z., Dong, M., Wang, S., Huang, L., Wang, J., Zhang, X., & Liu, F. (2026) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2026.105821 · Cited by 1
Jiang, R., Wang, T., Yao, Y., Wu, J., Xu, T., Guo, X., Wang, F., Jiang, P., & Qu, F. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112672 · Cited by 1
The role of genetic and epigenetic factors in developing polycystic ovary syndrome
Koval, Y. E., Дмитриевна, К. Т., Игнатко, И. В., Bakhtiyarov, K. R., Gilmutdinova, I., & Владимировна, В. Е. (2026) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2026.766 · Cited by 1
Wang, J., Yang, Y., Wang, Z. X., Li, F., Shi, Z., Gao, T., & Chang, H. (2026) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2026.1836617 · Cited by 1
Polyendocrine Metabolic Ovarian Syndrome: A Brief Review
Bennani, S., & Foote, K. (2026) · American Journal of Lifestyle Medicine · doi:10.1177/15598276261478047 · Cited by 1
Mousavi, M. A., Naz, M. S. G., Noroozzadeh, M., Azizi, F., & Tehrani, F. R. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70322 · Cited by 1
Forslund, M., Melin, J. M., Joham, A. E., Piltonen, T., Rees, A., & Teede, H. J. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70156 · Cited by 2
Jahan, N., Padder, K. A., Shah, I. A., Rashid, A., Yousuf, M. A., Wani, I. A., Godha, M., & Ganie, M. A. (2026) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-026-01451-3 · Cited by 1
Zhao, L., Li, P., Li, J., Liu, H., Wang, J., Qing, L., Yang, J., Wang, X., & 哈灵侠 (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02259-8 · Cited by 1
Pathogenesis of endothelial dysfunction in polycystic ovary syndrome
Tsar’kova, A. V., Balan, V. E., & Titchenko, Y. P. (2021) · Russian Journal of Human Reproduction · doi:10.17116/repro20212706147 · Cited by 1
The Role of Microparticles in Polycystic Ovarian Syndrome. An Updated Review
Almaghrabi, S. Y. (2022) · International Journal Of Pharmaceutical Research And Allied Sciences · doi:10.51847/eillcorjfq · Cited by 1
Li, J., Wang, G., Chu, S., Liu, D., Zhao, H., & Li, H. (2022) · Natural Product Communications · doi:10.1177/1934578x221129136 · Cited by 2
Importance of lifestyle modifications
Das, B., & Fatima, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00030-x · Cited by 1
Serum levels of ceruloplasmin and magnesium in polycystic ovarian syndrome: a cross sectional study
Misra, P., Nath, R. G., Naredi, N., Kandi, S. M., Raj, S., & Vashum, Y. (2023) · Exploration of Medicine · doi:10.37349/emed.2023.00140 · Cited by 1
Metadata
- Authors
- Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B.
- Affiliations
- Medical University of Warsaw (PL)
- Warsaw University of Life Sciences (PL)
- Department of Gynaecological Endocrinology, Poznan University of Medical Sciences, 60-535 Poznan, Poland
- Corresponding author
- Rudnicka, Ewa
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-06
- Volume
- 22
- Issue
- 7
- Pages
- 3789
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8038770
- OpenAlex
- W3145310045
- Cited by
- 680
- References
- 99
- Citations by year
- 2026: 152 · 2025: 172 · 2024: 165 · 2023: 112 · 2022: 74 · 2021: 5
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, low-grade inflammation, inflammatory cytokines, C-reactive protein, advanced glycation end products, RAGE, hyperinsulinemia, obesity, endothelial dysfunction, oxidative stress, cardiovascular risk, pregnancy complications, hyperandrogenism, insulin resistance
- MeSH terms
- Aging, C-Reactive Protein, Chronic Disease, Diabetes Mellitus, Type 2, Female, Humans, Inflammation, Obesity, Polycystic Ovary Syndrome, Cytokines, Metabolic Syndrome, Endothelial Cells, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.